For others, especially if their levels have been low for a while, it can take a few weeks and more than one injection to feel the full benefit
While not all of these uses are proven (and some may never be), the fact that semaglutide is being investigated for so many different conditions is very exciting, especially for those with PMOS

[4] [5] Appropriate clinical management for patients with comorbid metabolic conditions and problematic alcohol use should include: Comprehensive assessment of alcohol consumption patterns using validated screening tools (AUDIT, AUDIT-C) Referral to addiction medicine specialists or behavioral health providers for evidence-based AUD treatment, especially with red flags such as history of severe withdrawal, seizures, delirium tremens, pregnancy, severe liver disease, or suicidality Consideration of FDA-approved pharmacotherapies for alcohol use disorder (naltrexone, acamprosate, disulfiram) with attention to their specific contraindications [9] [11] If GLP-1 therapy is indicated for diabetes or obesity, close monitoring for changes in alcohol consumption and related behaviors Patient education emphasizing that any effects on alcohol cravings are not established therapeutic benefits Regular follow-up to assess medication adherence, adverse effects, and overall treatment response Patients should never discontinue evidence-based treatments for alcohol use disorder in favor of unproven approaches

**Diarrhea or Constipation**: Patients may experience changes in bowel habits
The combinations angiogenic effects are especially relevant here, since adequate blood supply is critical for bone repair
A healthier mucus layer means less intestinal permeability, which can reduce systemic inflammation." While the formulation is supported by current research, Perez says its effectiveness depends in part on your diet